RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Squamous Cell Carcinoma - Pipeline Review, Q4 2010
Dec 2010 - 27 pages - $500
Squamous Cell Carcinoma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 73 pages - $1,000
Renal Cell Carcinoma - Pipeline Review, Q3 2011
Jul 2011 - 390 pages - $500
Squamous Cell Carcinoma - Pipeline Review, H2 2011
Aug 2011 - 236 pages - $500
Renal Cell Carcimona Drug Discoveries - what the future holds
Feb 2010 - 138 pages - $2,265
Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy
Feb 2011 - 6 pages - $500
Islet cell carcinoma (Neuroendocrine Tumors) - Pipeline Review, Q2 2011
Jun 2011 - 50 pages - $500
Renal Cell Carcinoma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 75 pages - $1,000
Basal Cell Carcinoma - Pipeline Review, Q2 2011
Jun 2011 - 58 pages - $500
Squamous Cell Carcinoma - Pipeline Review, Q2 2011
Apr 2011 - 226 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Medical device del
Therapeutic target
Oncology del
Stomach/Esophageal del
Squamous cell carcinoma del
Year
2001 del

Browse By

Industry sector
Therapeutic device
Therapeutic medical equipment
Vision Care

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us